TrialHuman vaccines & immunotherapeutics2020

Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial.

Fabien Zoulim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.